← Back to Search

Highly Microbiota-Accessible Foods (HMAFs) intervention for Breast Cancer

N/A

Waitlist Available

Led By William J. McCarthy

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to six months follow-up

Awards & highlights

Study Summary

This trial is testing two different approaches to help breast cancer survivors lose excess body fat. One approach is focused on weight loss through calorie restriction and increased physical activity, while the other is intended to be a low-numeracy version of a Mediterranean-style diet and increased physical activity. The trial includes 30 participants and will assess systemic inflammation, gut microbiota, insulin resistance, and other health outcomes.

Eligible Conditions

Breast Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to six months follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to six months follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to six months follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

High-sensitivity C-Reactive Protein (CRP)

Secondary outcome measures

Number of highly microbiota-accessible foods consumed per day

Shannon index of alpha diversity of fecal microbial species

Visceral fat as assessed by DXA

Other outcome measures

Body mass index (BMI)

HDL-cholesterol

Health-related quality of life

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Highly Microbiota-Accessible Foods (HMAFs) interventionExperimental Treatment1 Intervention

The Highly Microbiota-Accessible Foods (HMAFs) lifestyle change intervention is designed to help overweight breast cancer survivors reduce their risk of breast cancer recurrence by reducing their elevated low-grade inflammation.

Group II: Diabetes Prevention Program-based lifestyle change intervention (DPP)Active Control1 Intervention

The Diabetes Prevention Program-based lifestyle change intervention (DPP) is designed to help overweight breast cancer survivors to reduce their risk of breast cancer recurrence by reducing their excess body fat.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,530 Previous Clinical Trials

10,278,172 Total Patients Enrolled

8 Trials studying Breast Cancer

1,642 Patients Enrolled for Breast Cancer

William J. McCarthyPrincipal InvestigatorUniversity of California, Los Angeles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for enrolment in this research trial?

"Affirmative, the information posted on clinicaltrials.gov reveals that recruitment for this medical trial is currently underway. The study was initially published on April 1st 2022 and has been modified since then. Thirty patients are required to be enrolled at one site."

Answered by AI

What type of individual would be most suited for this medical study?

"Patients with breast cancer between the ages of fifty and seventy-five can apply to become part of this medical trial, admitting up to 30 participants."

Answered by AI

Are participants of 30 years and over eligible to join this investigation?

"The current recruitment for this trial is limited to individuals aged 50-75."

Answered by AI

What is the aggregate figure of individuals participating in this clinical exploration?

"Affirmative. According to the details on clinicaltrials.gov, this trial is currently recruiting participants since its first posting on April 1st 2022 and latest update on that same date. The research team are in need of 30 volunteers from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

UCLA Breast Cancer Survivor Health Promotion Research Study

William J. McCarthy, Ph.D. 2022. "UCLA Breast Cancer Survivor Health Promotion Research Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05113485.